Pardon our progress.

Survival rates at one year for patients with melanoma brain mets have nearly doubled (12% → 22%) in only a decade from 2007 - 2016. This is occurring at the same time the use of BRAF/MEK inhibitors is soaring (<2% → 50%) and whole brain radiation is declining (75% → 52%) in favor of radiosurgery (3% → 21%). | Brastianos, JAMA Netw Open 2020